ANI Pharmaceuticals to Present at Guggenheim's Inaugural Healthcare Innovation Conference and Jefferies London Healthcare Conference in November

Group 1 - ANI Pharmaceuticals, Inc. will present at two upcoming investor conferences: the Guggenheim Inaugural Healthcare Innovation Conference on November 13, 2024, and the Jefferies London Healthcare Conference on November 20, 2024 [1] - The presentations will be made by Nikhil Lalwani, President and CEO, and Stephen Carey, CFO [1] - Live and archived webcasts of the presentations will be available on the company's website for 90 days [1] Group 2 - ANI Pharmaceuticals is a diversified biopharmaceutical company focused on developing, manufacturing, and commercializing innovative therapeutics [2] - The company aims for sustainable growth through its Rare Disease business, Generics business, and Established Brands business [2] - ANI Pharmaceuticals markets products in various therapeutic areas including ophthalmology, rheumatology, nephrology, neurology, and pulmonology [2]